Grants
Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor | Date |
---|---|---|---|---|---|---|---|
Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner 1 (MOBI-1) | Contract | $100,800.00 | Clinical Trial | Bellal Joseph | Surgery | University of Alabama at Birmingham | 05/2022 |
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP II TR): A prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Tran | Contract | $159,060.24 | Clinical Trial | Marvin Eng | COM Phx Internal Medicine | Edwards Lifesciences LLC | 05/2022 |
CCC for NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Network (ASTER Protocol) | Cooperative Agreement | $784,294.00 | Clinical Trial | Jarrod Mosier | Dept of Emergency Medicine | Albert Einstein College of Medicine | 05/2022 |
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Adult Subjects with Classic Congenital Adrenal Hyperplasia | Contract | $56,351.04 | Clinical Trial | Rong Guo | COM Phx Internal Medicine | Spruce Biosciences, Inc. | 05/2022 |
A Phase IIb Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of Atacicept in Subjects with IgA Nephropathy (IgAN) | Contract | $140,362.88 | Clinical Trial | Amy Sussman | Medicine | Vera Therapeutics Inc | 05/2022 |
A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib | Contract | $28,800.00 | Clinical Trial | Holly Pariury | Cancer Center Division | Public Health Institute | 05/2022 |
A Phase 1/2, Open Label, Dose-Escalation Study Of Oral ORIN1001 With And Without Chemotherapy In The Treatment Of Subjects With Solid Tumors | Contract | $245,863.24 | Clinical Trial | Pavani Chalasani | Cancer Center Division | Orinove Inc. | 05/2022 |
A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering from Plaque Psoriasis Through Clinical Utility and Health Outcomes. (MATCH | Contract | $82,003.00 | Clinical Trial | Jawad Bilal | Arthritis Center-Research | Mindera Corporation | 05/2022 |
The Effect of Morphine on Fracture Healing in Mice | Grant | $460.50 | Research Training | David Margolis | Orthopedic Surgery | Arizona State University | 04/2022 |
Role of Renal Nerves in Cardiovascular and Renal Dysfunction in Polycystic Kidney Disease | Fellowship | $64,072.00 | Research Training | Madeline Gauthier | Physiology | American Heart Association, Incorporated | 04/2022 |
Novel Cutaneous Squamous Cell Carcinoma Model to Investigate Tumor-Specific T Cell Responses | Fellowship | $7,000.00 | Research Training | Anngela Adams | COM Phx Basic Medical Sci | American Skin Association | 04/2022 |
Histological Analysis of Stem Cells Cultured on Bone Regeneration Scaffolds | Grant | $460.50 | Research Training | David Margolis | Orthopedic Surgery | Arizona State University | 04/2022 |
Evaluation of Calcium Phosphate Ceramic Coating in Cell Culture | Grant | $460.50 | Research Training | David Margolis | Orthopedic Surgery | Arizona State University | 04/2022 |
Continued PCR Analysis of Pluripotent and Terminally Differentiated Cells for Tissue Regeneration - WAESO | Grant | $460.50 | Research Training | John Szivek | Orthopedic Surgery | Arizona State University | 04/2022 |
Combining 3D Hydrogel Cell and Thermoplastic Printing | Grant | $460.50 | Research Training | David Margolis | Orthopedic Surgery | Arizona State University | 04/2022 |
Validation of Epigenomic Biomarkers for Thyroid Cancer Diagnostics | Grant | $53,011.00 | Research | Marlon Guerrero | Surgery | City of Hope | 04/2022 |
Targeted Biomarker Panels and Pre-processing Device for the Rapid Assessment of Radiation Injury in Easily Accessible Biofluids | Grant | $151,026.00 | Research | Frederic Zenhausern | COM Phx NanoBioscience & Med | Georgetown University | 04/2022 |
Surface Receptor Deglycosylation: A Triggering Mechanism of Platelet Dysfunction In Mechanical Circulatory Support | Grant | $231,000.00 | Research | Yana Roka Moiia | UAHS Research | American Heart Association, Incorporated | 04/2022 |
Long acting and peripherally restricted kappa-opioid receptor agonists for acute migraine treatment | Grant | $38,508.00 | Research | Frank Porreca | Pharmacology | Peptide Logic, LLC | 04/2022 |
LAAZ-NPH Clinical Center | Cooperative Agreement | $359,052.00 | Research | Francisco Moreno | All of Us Research Program | Pennington Biomedical Research Center | 04/2022 |
Engineering 2nd Generation 5MCARs to Monitor and Treat Type-I Diabetes | Grant | $3,325,791.00 | Research | Michael Kuhns | Immunobiology | National Institute of Diabetes and Digestive and Kidney Diseases | 04/2022 |
Development of Non-Catalytic Peptide Inhibitors of Focal Adhesion Kinase (FAK) for Use in Melanoma | Grant | $599,775.00 | Research | Noel Warfel | Cellular & Molecular Medicine | FAKnostics, LLC | 04/2022 |
DNA methylation, Liquid Biopsy, and Pancreatic Cancer | Grant | $394,687.00 | Research | Mark Nelson | Pathology | National Cancer Institute | 04/2022 |
COVID-19 Testing and Vaccine Research - Pandemic Response to Underserved Populations | Grant | $47,250.00 | Research | Velia Nuno | Health Promotion Sciences | Arizona State University | 04/2022 |
Building Translational Research & Development, Mentorship, and Diversity | Grant | $5,363,744.00 | Research | Guy Reed | COM Phx Internal Medicine | University of Arizona Foundation | 04/2022 |